Who makes Non-active base from azelaic acid 15% gel?

Non-active base from azelaic acid 15% gel is developed by LEO Pharma.

What development phase is Non-active base from azelaic acid 15% gel in?

Non-active base from azelaic acid 15% gel is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Non-active base from azelaic acid 15% gel

LEO Pharma · Phase 2 active Small molecule

At a glance

Generic name	Non-active base from azelaic acid 15% gel
Sponsor	LEO Pharma
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Non-active base from azelaic acid 15% gel CI brief — competitive landscape report
Non-active base from azelaic acid 15% gel updates RSS · CI watch RSS
LEO Pharma portfolio CI